Daejung Chemicals & Metals Co., Ltd 120240
KRX · South Korea · Process Industries
KRW 14,800.00-60.00 (-0.40%)
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
MakklerAI · PRO
MakklerPRO is required for MakklerAI questions and forward scenarios grounded in structured data for the selected stock.
Upgrade to MakklerPROUpgrade to MakklerPRO to see the Makkler Fair Value calculation, the fundamental score and the multiples behind it.
Upgrade to MakklerPROUpgrade to MakklerPRO to see a 1-5 score for profitability, growth, cash-flow quality, and balance-sheet health.
Upgrade to MakklerPROUpgrade to MakklerPRO to see an AI-generated executive summary and bull/bear breakdown built from this stock's financial data.
Upgrade to MakklerPRO| Company | Market cap | P/E | P/B | P/S | Net margin | Revenue growth | Dividend yield | Beta |
|---|---|---|---|---|---|---|---|---|
| 120240Daejung Chemicals & Metals Co., Ltd | KRW 106.59B | 6.2 | 0.6 | 0.9 | 14.3% | 23.0% | 3.2% | 0.1 |
| 083420Green Chemical Co., Ltd. | KRW 109.05B | 5.5 | 0.8 | 0.4 | 6.4% | -1.7% | 5.1% | 0.2 |
| 187790NANO Co., Ltd. | KRW 97.22B | 61.3 | 2.3 | 1.0 | 1.7% | 22.2% | 0.0% | 1.1 |
| 015890Taekyung Industrial Co., Ltd. | KRW 138.69B | 4.1 | 0.3 | 0.1 | 3.2% | 18.0% | 5.3% | 0.1 |
| 052260HYUNDAI BIOLAND Co.,Ltd. | KRW 156.00B | 11.2 | 1.0 | 1.1 | 9.5% | 14.1% | 1.3% | 0.3 |
| 214260RAPHAS CO. LTD. | KRW 65.50B | — | 2.5 | 2.2 | -18.2% | 4.5% | 0.0% | 0.1 |
| 102940Kolon Life Science Inc. | KRW 193.74B | 5.8 | 0.3 | 0.9 | 16.4% | 17.1% | 0.0% | 0.4 |
| 298000Hyosung Chemical Corp. | KRW 200.82B | — | 0.3 | 0.1 | 1.1% | 0.1% | 0.0% | 0.2 |
| 420570J2KBIO Co., Ltd. | KRW 55.26B | 9.1 | 1.4 | 1.3 | 13.2% | 51.0% | 2.6% | -0.1 |
| Peer median | 7.5 | 0.9 | 1.0 | 4.8% | 15.6% | 0.7% | 0.2 |
Peers are selected automatically from companies in the same industry. Extreme ratios (a loss-making company's P/E, or one distorted by a one-off item) are not adjusted away, which is why the summary row uses the median rather than the average. Not investment advice. The ratios in this table come from one outside provider for every company, so the comparison is internally consistent; they can differ from the filing-derived ratios higher up the page because the definitions differ.